Doctors disagree about directive on European clinical trials

BMJ 2007; 335 doi: (Published 04 October 2007) Cite this as: BMJ 2007;335:691
  1. Rory Watson
  1. Brussels

Contradictory details are emerging of the impact that the three year old European Union legislation on clinical trials is having on medical science.

According to research presented on 27 September at a conference in Barcelona organised by the European Cancer Organisation, the number of non-commercial clinical trials has fallen by a quarter. Markus Hartmann, from European Consulting and Contracting in Oncology, Trier, Germany, told participants that this figure was a “conservative estimate.”

But data from the European Medicines Evaluation Agency show that the percentage of non-commercial trials increased between 2005 and 2006. The agency and the European Commission launched consultations at a conference in …

View Full Text

Log in

Log in through your institution


* For online subscription